On March 18th, according to Interface News, Hou Yi officially stepped down from his position as CEO of Hema and continued to serve as Hema's Chief Honorary Advisor, with Hema CEO Yan Xiaolei taking over. Just now, Alibaba Group CEO Wu Yongming notified Hema employees of the above-mentioned personnel changes through a full staff email.